Home
Hainan Poly Pharm. Co., Ltd(Poly Pharm) is pleased to announce its participation in the DCAT Week 2026 (Drug, Chemical&Associated Technologies Association), the premier global event convening for the Bio/Pharmaceutical development and business community. This event will take place in New York City from March 23-26, 2026.
As a vertically integrated pharmaceutical company with a strong track record in international regulatory compliance, including repeated approvals from the U.S. FDA, EU EMA, WHO, and other major health authorities, Poly Pharm specializes in the R&D, manufacturing and marketing of both API and finished pharmaceutical products. Poly Pharm will leverage this platform to deepen existing partnerships and explore new strategic collaborations across North America, Europe, and beyond.
During DCAT week, member of Poly Pharm’s Business Development team will be available for private meetings at the Hotel 48LEX New York Suite 504. Parties interested in scheduling a meeting with Poly Pharm during DCAT Week are invited to contact:
Mr. Liu Huan
Director of US market and Emerging Market II
Email: liuhuan@hnpoly.com
